Next Chems

Next Chems lists 47 products on Peptides.SO, 31 of them SARMs and research chemicals, one of four platform catalogues where peptides are the minority. Thirty of the 47 listings are capsule format and five are oral solutions, 37 were in stock at the last feed pass, and 18 carried a sale price.

Catalogue shape from platform data: the SARM and research-chemical block covers RAD-140 in capsule, solution and RAD-150 forms, GW-501516 in capsule and solution, S-4, S-23, YK-11, AC-262, ACP-105, SR-9009 and SR-9011 solutions and capsules, MK-677 10mg at two prices, RU58841 solution, a 1,3-DMAA solution and a set of capsule-form pharmaceutical-class compounds (selective oestrogen receptor modulators, an aromatase inhibitor, PDE5 inhibitors, beta blockers, a statin, an antihypertensive and others) that fall outside the peptide category entirely. Cognitive items (7) are capsule nootropics: Noopept 30mg ($24.99), Piracetam 800mg ($19.99), Bromantane 25mg, 9-Me-BC 15mg, NSI-189 phosphate 20mg, Flmodafinil 50mg and Dihexa 5mg, all in 60-count bottles. The peptide-adjacent entries are BPC-157 ($114.95, on sale at $85.95), a 70mg GLOW blend of GHK-Cu, TB-500 and BPC-157 ($158), 5-Amino-1MQ ($249, sale $119.99) and Tesofensine ($185.99). Two cardiovascular capsule products, a hydrochlorothiazide entry and a $1 test product round out the feed.

Against the rest of the platform, only seven Next Chems products overlap with ten or more other suppliers. MK-677 10mg is below the median at $71.95 and $89.95 (on sale at $69.95) against $110.50 across 30 suppliers. GW501516 at $69.96 and YK-11 at $111.95 (sale $68.95) sit exactly on their $69.96 and $111.95 medians at list. BPC-157 at $114.95 is above the $90 median across 91 suppliers, though its $85.95 sale price drops under it, 5-Amino-1MQ at $249 is three times the $79.99 median at list (the $119.99 sale price is still above) and Tesofensine at $185.99 is on the $180 median. Capsule and solution formats do not map onto the platform's lyophilised-vial medians, so the remaining 40 listings have no meaningful cross-supplier comparison.

Verification status on Peptides.SO: Next Chems is not platform-verified, has a testing score of 0 out of 7 criteria and no Certificate of Analysis linked, and has no platform reviews yet. No payment-method data has been captured from the storefront. That gap is shared across the platform, where no active supplier currently records a testing criterion or COA and only 3 of 169 are verified, so request batch-specific analytical documentation from the supplier before ordering; for capsule products ask for content-per-capsule assay results rather than raw-material purity alone. Sixteen of the 47 listings were refreshed by the September 2026 feed; 31 still show March 2026 prices.

Common questions. Is Next Chems a peptide supplier? Only marginally: four listings are peptides or peptide blends, and the rest are SARMs, nootropics and pharmaceutical-class compounds in capsule or solution form. Where does it price below the platform? MK-677 10mg, and BPC-157 at its sale price. Where is it above? 5-Amino-1MQ and BPC-157 at list.

Products from suppliers listed on Peptides.SO are for laboratory research use only and are not approved or intended for human or animal use, diagnosis, treatment or consumption.